Evidence map›Paper›PMID 23466454›Full record

ArticleBone2013

PTH prevents the adverse effects of focal radiation on bone architecture in young rats.

Abhishek Chandra, Shenghui Lan, Ji Zhu, Tiao Lin, Xianrong Zhang, Valerie A Siclari, Allison R Altman, Keith A Cengel, X Sherry Liu, Ling Qin

Open access · greenAbstract read
In one paragraph

Article in Bone, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed
3.6field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 52 citations in OpenAlex.

  1. Review
  2. Orchestrated delivery of PTH [1-34] followed by zoledronic acid prevents radiotherapy-induced bone loss but does not abrogate marrow damage.Journal of orthopaedic research : official publication of the Orthopaedic Research Society · 2022
    Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Periosteal Mesenchymal Progenitor Dysfunction and Extraskeletally-Derived Fibrosis Contribute to Atrophic Fracture Nonunion.Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research · 2019
    Article
  8. Article
  9. Proteasome inhibitor bortezomib is a novel therapeutic agent for focal radiation-induced osteoporosis.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2018
    Article
  10. Article
  11. Longitudinal Effects of Single Hindlimb Radiation Therapy on Bone Strength and Morphology at Local and Contralateral Sites.Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research · 2018
    Article
  12. Review
  13. PTH(1-34) and zoledronic acid have differing longitudinal effects on juvenile mouse femur strength and morphology.Journal of orthopaedic research : official publication of the Orthopaedic Research Society · 2017
    Article
  14. Suppression of Sclerostin Alleviates Radiation-Induced Bone Loss by Protecting Bone-Forming Cells and Their Progenitors Through Distinct Mechanisms.Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research · 2017
    Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Abhishek ChandraDepartment of Orthopaedic Surgery, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA. abhic@mail.med.upenn.edu
Shenghui Lan
Ji Zhu
Tiao Lin
Xianrong Zhang
Valerie A Siclari
Allison R Altman
Keith A Cengel
X Sherry Liu
Ling Qin
University of Pennsylvania · US

Funding

The Role of Hyaluronic Acid Receptors in Tendon HealingP30AR050950 · NIAMS · UNIVERSITY OF PENNSYLVANIA · PI BALDWIN, DONALD A · 2006 to 2015
$6.2M
Training Program in Cancer PharmacologyR25CA101871 · NCI · UNIVERSITY OF PENNSYLVANIA · PI BLAIR, IAN ALEXANDER · 2003 to 2013
$4.3M
The role of amphiregulin in PTH's action on boneK01DK071988 · NIDDK · UNIV OF MED/DENT NJ-R W JOHNSON MED SCH · PI QIN, LING · 2005 to 2008
$531k
NCI NIH HHS R25 CA101871NCI NIH HHS R25 CA101871-07NIAMS NIH HHS P30 AR050950NIAMS NIH HHS P30AR050950NIDDK NIH HHS K01 DK071988
6 · The paper itself

Abstract

Radiation therapy is a common treatment regimen for cancer patients. However, its adverse effects on the neighboring bone could lead to fractures with a great impact on quality of life. The underlying mechanism is still elusive and there is no preventive or curative solution for this bone loss. Parathyroid hormone (PTH) is a current therapy for osteoporosis that has potent anabolic effects on bone. In this study, we found that focal radiation from frequent scans of the right tibiae in 1-month-old rats by micro-computed tomography severely decreased trabecular bone mass and deteriorated bone structure. Interestingly, PTH daily injections remarkably improved trabecular bone in the radiated tibiae with increases in trabecular number, thickness, connectivity, structure model index and stiffness, and a decrease in trabecular separation. Histomorphometric analysis revealed that radiation mainly decreased the number of osteoblasts and impaired their mineralization activity but had little effects on osteoclasts. PTH reversed these adverse effects and greatly increased bone formation to a similar level in both radiated and non-radiated bones. Furthermore, PTH protects bone marrow mesenchymal stem cells from radiation-induced damage, including a decrease in number and an increase in adipogenic differentiation. While radiation generated the same amount of free radicals in the bone marrow of vehicle-treated and PTH-treated animals, the percentage of apoptotic bone marrow cells was significantly attenuated in the PTH group. Taken together, our data demonstrate a radioprotective effect of PTH on bone structure and bone marrow and shed new light on a possible clinical application of anabolic treatment in radiotherapy.

Indexed as

AgingAnimalsMaleMesenchymal Stem CellsParathyroid HormoneRadiation-Protective AgentsRadiotherapyRatsRats, Sprague-DawleyTibiaX-Ray MicrotomographyParathyroid HormoneRadiation-Protective Agents

Identifiers

PMID23466454
PMCPMC3679252
OpenAlexW2114852271

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.